Prabhudas Lilladher Recommends Accumulating Dr. Reddy’s, Sets Rs 1,350 Target
Prabhudas Lilladher says Dr. Reddy’s Q2FY27 EBITDA was about INR 17 billion, with a 19.1% operating margin, above its estimate. The report cites licensing and milestone income, lower R&D spending and US exclusivity opportunities.